βοΈ Technology Apr 10, 2026
Hamilton Medical G7 Ventilator Cleared by FDA: Adaptive Support Ventilation 2.0 and AI-Guided PEEP Titration
The Hamilton Medical HAMILTON-G7 intelligent ventilator has received FDA 510(k) clearance, featuring an upgraded Adaptive Support Ventilation 2.0 (ASV 2.0) algorithm and an embedded AI-guided PEEP titration tool validated against esophageal pressure-guided optimization.
π NBRC Updates β‘ NBRC Mar 15, 2026
NBRC Updates CRT-to-RRT Pathway: Reduced Minimum Clinical Hours Requirement
The NBRC has revised the pathway from Certified Respiratory Therapist (CRT) to Registered Respiratory Therapist (RRT), reducing the required minimum clinical hours and allowing accelerated examination eligibility for graduates of CAAHEP-accredited programs with 3.0+ GPA.
π₯ AARC β‘ NBRC Feb 28, 2026
AARC New CPG: Liberation from Mechanical Ventilation in Adult ICU Patients
The AARC has released a new Clinical Practice Guideline on liberation from mechanical ventilation in critically ill adults, formally endorsing RT-driven liberation protocols, daily spontaneous awakening trials (SAT), and validating the RSBI as the primary weaning predictor.
π¬ Research Jan 28, 2026
RSV Season 2025-2026: Evolving RT Management Protocols and Prophylaxis Updates
The 2025-2026 respiratory virus season features co-circulation of RSV, influenza A/B, and SARS-CoV-2 subvariants. Updated prophylaxis (nirsevimab for infants, RSV maternal vaccine) and RT management protocols for RSV bronchiolitis are reviewed.
π Guidelines β‘ NBRC Jan 10, 2026
GOLD 2026 Report: Updated COPD Phenotype Classification and Treatment Algorithm
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 report introduces a refined ABCD assessment tool incorporating eosinophil counts and exacerbation history into initial pharmacotherapy selection, replacing the 2019 ABCD grouping.
π Pharmacology β‘ NBRC Dec 5, 2025
Dupilumab Receives Expanded Indication: Moderate-to-Severe Asthma Ages 6+ Without Eosinophil Requirement
The FDA has approved an expanded indication for dupilumab (Dupixent) for uncontrolled moderate-to-severe asthma, removing the previously required minimum blood eosinophil threshold and extending approval to patients aged 6 years and older.
π Guidelines Nov 20, 2025
AASM Updates OSA Management Guidelines: Positional Therapy and CPAP Alternatives
The American Academy of Sleep Medicine (AASM) has released updated clinical practice guidelines for the management of adult obstructive sleep apnea (OSA), expanding evidence-based recommendations for positional therapy, hypoglossal nerve stimulation, and PAP adherence interventions.
π₯ AARC β‘ NBRC Oct 14, 2025
AARC Releases Updated CPG: High-Flow Nasal Cannula in Adults
The American Association for Respiratory Care (AARC) has published an updated Clinical Practice Guideline (CPG) for high-flow nasal cannula (HFNC) oxygen therapy in adult patients, incorporating evidence on pre-oxygenation, post-extubation use, and HFNC in immunocompromised patients.
βοΈ Technology Sep 30, 2025
DrΓ€ger Babylog VN800: FDA Clearance for Neurally Adjusted Ventilatory Assist (NAVA) in Neonates < 1 kg
DrΓ€ger Medical has received FDA clearance for an expanded weight range for Neurally Adjusted Ventilatory Assist (NAVA) mode on the Babylog VN800 neonatal ventilator, now approved for use in neonates weighing as little as 500 grams.
π Guidelines β‘ NBRC Sep 10, 2025
ATS/ESICM Issue Revised Global ARDS Definition: Key Changes from Berlin 2012
A joint ATS/ESICM/SCCM task force has published a revised global ARDS definition expanding the Berlin criteria to include high-flow nasal cannula (HFNC) as an eligible respiratory support modality, and introducing the Global ARDS Severity Score (GASS) to replace P/F ratio categories.
π NBRC Updates β‘ NBRC Aug 1, 2025
NBRC Announces 2026 RRT Examination Restructuring: Content Blueprint Updates
The National Board for Respiratory Care (NBRC) has announced significant blueprint changes to the Registered Respiratory Therapist (RRT) Written Registry Exam effective January 2026, including increased weighting of critical care and simulation-based content areas.
π Pharmacology Jul 22, 2025
FDA-Approved Terlipressin: Vasopressor Implications for Septic Shock Management
Terlipressin, a synthetic vasopressin analogue, has received expanded FDA approval for vasodilatory shock refractory to catecholamines. RT practitioners should understand its hemodynamic effects and implications for oxygenation management in critically ill patients.